UiPath Inc <PATH.N>: RBC cuts target price to $15 from $17
PATH•Related News
Novo Nordisk open to New York listing upgrade, CEO Doustdar tells FT
NVO•
LS Corp says talks continue with UK authorities on possible high-voltage cable plant investment
XLI•
Viking Therapeutics, Inc. <VKTX.O>: Truist Securities raises target price to $87 from $83
VKTX•
Anixa Biosciences Inc <ANIX.O>: H.C. Wainwright cuts target price to $6 from $7
ANIX•
Gran Tierra Energy Inc.: Roth MKM raises target price to C$18.5 from C$17.5
GTE•